Our top pick for
ALLETE, Inc is an utilities-diversified business based in the US. ALLETE shares (ALE) are listed on the NYSE and all prices are listed in US Dollars. ALLETE employs 1,322 staff and has a trailing 12-month revenue of around USD$1.2 billion.
|52-week range||USD$46.7389 - USD$73.4313|
|50-day moving average||USD$64.8624|
|200-day moving average||USD$58.1097|
|Wall St. target price||USD$70|
|Dividend yield||USD$2.47 (3.94%)|
|Earnings per share (TTM)||USD$3.35|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing ALLETE stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ALLETE's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ALLETE's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, ALLETE shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
ALLETE's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.71. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ALLETE's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
ALLETE's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$376.3 million.
The EBITDA is a measure of a ALLETE's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$1.2 billion|
|Operating margin TTM||13.64%|
|Gross profit TTM||USD$424.8 million|
|Return on assets TTM||1.72%|
|Return on equity TTM||6.29%|
|Market capitalisation||USD$3.2 billion|
TTM: trailing 12 months
There are currently 1.1 million ALLETE shares held short by investors – that's known as ALLETE's "short interest". This figure is 9.7% down from 1.2 million last month.
There are a few different ways that this level of interest in shorting ALLETE shares can be evaluated.
ALLETE's "short interest ratio" (SIR) is the quantity of ALLETE shares currently shorted divided by the average quantity of ALLETE shares traded daily (recently around 374715.12027491). ALLETE's SIR currently stands at 2.91. In other words for every 100,000 ALLETE shares traded daily on the market, roughly 2910 shares are currently held short.
However ALLETE's short interest can also be evaluated against the total number of ALLETE shares, or, against the total number of tradable ALLETE shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ALLETE's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 ALLETE shares in existence, roughly 20 shares are currently held short) or 0.0271% of the tradable shares (for every 100,000 tradable ALLETE shares, roughly 27 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ALLETE.
Find out more about how you can short ALLETE stock.
Dividend payout ratio: 70.73% of net profits
Recently ALLETE has paid out, on average, around 70.73% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.02% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), ALLETE shareholders could enjoy a 4.02% return on their shares, in the form of dividend payments. In ALLETE's case, that would currently equate to about $2.47 per share.
ALLETE's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
ALLETE's most recent dividend payout was on 1 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 12 February 2021 (the "ex-dividend date").
ALLETE's shares were split on a 1:3 basis on 21 September 2004. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ALLETE shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for ALLETE shares which in turn could have impacted ALLETE's share price.
Over the last 12 months, ALLETE's shares have ranged in value from as little as $46.7389 up to $73.4313. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while ALLETE's is 0.4472. This would suggest that ALLETE's shares are less volatile than average (for this exchange).
ALLETE, Inc. operates as an energy company. The company operates through Regulated Operations, ALLETE Clean Energy, and Corporate and Other segments. It generates electricity from coal-fired, biomass co-fired / natural gas, hydroelectric, wind, and solar. The company provides regulated utility electric services in northwestern Wisconsin to approximately 15,000 electric customers, 13,000 natural gas customers, and 10,000 water customers, as well as regulated utility electric services in northeastern Minnesota to approximately 145,000 retail customers and 15 non-affiliated municipal customers. It also owns and maintains electric transmission assets in Wisconsin, Michigan, Minnesota, and Illinois. In addition, the company focuses on developing, acquiring, and operating clean and renewable energy projects; and owns and operates approximately 1,000 megawatts of wind energy generation facility. Further, it is involved in the coal mining operations in North Dakota; and real estate investment activities in Florida. The company owns and operates 158 substations with a total capacity of 10,066 megavolt amperes. It serves taconite mining, paper, pulp and secondary wood products, pipeline, and other industries. The company was formerly known as Minnesota Power, Inc. and changed its name to ALLETE, Inc. in May 2001. ALLETE, Inc. was incorporated in 1906 and is headquartered in Duluth, Minnesota.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.